Patent · US Active

Matrix composed of a naturally-occurring protein backbone cross linked by a synthetic polymer and methods of generating and using same

US9700600B2 · kind B2 · utility

0Cited by
34References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 31, 2015
Grant dateJul 11, 2017
Priority date
Expiry dateSep 21, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2533/54
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A method of treating a disorder characterized by tissue damage is provided. The method comprising providing to a subject in need-thereof a composition which comprises a synthetic polymer attached to denatured fibrinogen or a therapeutic portion of the fibrinogen, the composition being formulated for releasing the therapeutic portion of the fibrinogen in a pharmacokinetically regulated manner, thereby treating the disorder characterized by tissue damage or malformation.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.